World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
20209
World Ranking
2650
National Ranking
9

Ed C. Lavelle publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ed C. Lavelle sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 174 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ed C. Lavelle D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ed C. Lavelle sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ed C. Lavelle is affiliated with Trinity College Dublin in Ireland and focuses on research primarily within the fields of Immunology and Microbiology as well as Medicine. Their work has contributed to various subfields including Immunology, Infectious Diseases, Molecular Biology, Cancer Research, and Epidemiology.

They have been involved in the publication of multiple scientific papers, with notable recent contributions such as:

  • Mucosal vaccines - fortifying the frontiers, 2021, Nature reviews. Immunology
  • Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages, 2021, Nature Communications
  • Mycobacterium tuberculosis Limits Host Glycolysis and IL-1β by Restriction of PFK-M via MicroRNA-21, 2020, Cell Reports
  • Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity, 2020, European Journal of Immunology
  • Modulation of immune responses using adjuvants to facilitate therapeutic vaccination, 2020, Immunological Reviews

Lavelle has co-authored with multiple frequent collaborators including Ross W. Ward, Natalia Muñoz-Wolf, Aoife L. Gorman, Roisin I. Lynch, and Filipa Lebre. These collaborations have supported their contributions to the scientific community.

Their research has been disseminated in a range of publication venues, with multiple papers appearing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature reviews. Immunology
  • Nature Communications
  • European Journal of Immunology
  • Current Opinion in Immunology

Key topics evident in Lavelle's body of work include:

  • Immunotherapy and Immune Responses
  • Immune responses and vaccinations
  • Immune Response and Inflammation
  • SARS-CoV-2 and COVID-19 Research
  • Immune cells in cancer
  • Inflammasome and immune disorders
  • Immune Cell Function and Interaction

The scope of their research broadly addresses the dynamics of immune responses, vaccinations, and inflammation, with an emphasis on understanding mechanisms relevant to infectious diseases and cancer.

Best Publications

  • Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

    Caroline E. Sutton;Stephen J. Lalor;Cheryl M. Sweeney;Corinna F. Brereton

  • Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

    Seth L Masters;Aisling Dunne;Shoba L Subramanian;Rebecca L Hull

  • A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis

    Caroline Sutton;Corinna Brereton;Brian Keogh;Kingston H.G. Mills

  • Autophagy Controls IL-1β Secretion by Targeting Pro-IL-1β for Degradation

    James Harris;Michelle L Hartman;Caitrionna Jane Roche;Shijuan Grace Zeng

  • Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases

    Alexander U. Lüthi;Sean P. Cullen;Edel A. McNeela;Patrick J. Duriez

  • Mucosal vaccines - fortifying the frontiers.

    Ed C. Lavelle;Ross W. Ward

  • Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

    Fiona A Sharp;Darren Thomas Ruane;Benjamin Claass;Emma Creagh

  • The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons

    Elizabeth C. Carroll;Lei Jin;Andres Mori;Natalia Muñoz-Wolf

  • TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

    Sarah C. Higgins;Andrew G. Jarnicki;Ed C. Lavelle;Kingston H. G. Mills

  • NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components

    Sarah L. Doyle;Matthew Campbell;Ema Ozaki;Robert G. Salomon

  • Pneumolysin Activates the NLRP3 Inflammasome and Promotes Proinflammatory Cytokines Independently of TLR4

    Edel A. McNeela;Áine Burke;Daniel R. Neill;Cathy Baxter

  • Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine

    Pádraig J. Ross;Caroline E. Sutton;Sarah Higgins;Aideen C. Allen

  • Toll-Like Receptor 4-Mediated Innate IL-10 Activates Antigen-Specific Regulatory T Cells and Confers Resistance to Bordetella pertussis by Inhibiting Inflammatory Pathology

    Sarah C. Higgins;Ed C. Lavelle;Chantelle McCann;Brian Keogh

  • Granzyme B-Dependent Proteolysis Acts as a Switch to Enhance the Proinflammatory Activity of IL-1α

    Inna S. Afonina;Graham A. Tynan;Susan E. Logue;Sean P. Cullen

  • The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis.

    E C Lavelle;C Murphy;L A J O’Neill;E M Creagh

  • Fas/CD95-Induced Chemokines Can Serve as “Find-Me” Signals for Apoptotic Cells

    Sean P. Cullen;Conor M. Henry;Conor J. Kearney;Susan E. Logue

  • Trends in vaccine adjuvants.

    Virgil E J C Schijns;Ed C Lavelle

  • Immunomodulatory properties of chitosan polymers

    Hannah B.T. Moran;Joanna L. Turley;Mats Andersson;Ed C. Lavelle

  • Immunomodulatory properties of the vaccine adjuvant alum.

    Ewa Oleszycka;Ed C Lavelle

  • The shape and size of hydroxyapatite particles dictate inflammatory responses following implantation.

    Filipa Lebre;Rukmani Sridharan;Michael J Sawkins;Michael J Sawkins;Daniel J Kelly;Daniel J Kelly

  • Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics

    Andrew G. Jarnicki;Helen Conroy;Corinna Brereton;Graham Donnelly

Frequent Co-Authors

Kingston H. G. Mills
Kingston H. G. Mills Trinity College Dublin
Derek O'hagan
Derek O'hagan GlaxoSmithKline (United Kingdom)
James S. Harris
James S. Harris Stanford University
S.S. Davis
S.S. Davis University of Nottingham
Seamus J. Martin
Seamus J. Martin Trinity College Dublin
Luke A. J. O'Neill
Luke A. J. O'Neill Trinity College Dublin
Katherine A. Fitzgerald
Katherine A. Fitzgerald University of Massachusetts Chan Medical School
George Grant
George Grant University of Aberdeen
Paul F. Kenna
Paul F. Kenna Trinity College Dublin
Fergal J. O'Brien
Fergal J. O'Brien Royal College of Surgeons in Ireland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare and nursing degrees online can offer flexible pathways to advance your career. Many professionals begin with programs such as online ABSN programs for non nurses, which provide a fast track into nursing for individuals without prior healthcare backgrounds.

After obtaining a foundational nursing degree, accelerated options like the accelerated FNP program allow registered nurses to specialize as Family Nurse Practitioners quickly, which is valuable in many immunology-related clinical settings.

For those seeking further specialization, pursuing an acute care NP certification can open doors to critical care roles that often collaborate with immunology research and treatment teams.

Understanding potential earnings is also key when planning your pathway. Insights into how much do DNPs make can help set realistic expectations and guide your investment in advanced degrees.

Best Scientists Citing Ed C. Lavelle

Trending Scientists

Recently Published Articles